| P50 | author | Scott E Hemby | Q56816065 |
| P2093 | author name string | Steven R Childers | |
| | Tammy Sexton | |
| | Scot McIntosh | |
| | Lindsey P Pattison | |
| P2860 | cites work | Animal studies of addictive behavior | Q26823154 |
| | HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells | Q28144137 |
| | [125I]RTI-55: a potent ligand for dopamine transporters | Q28287191 |
| | HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures | Q28290856 |
| | Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen | Q28342058 |
| | The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 |
| | The neural basis of addiction: a pathology of motivation and choice | Q29615901 |
| | Molecular basis for interactions of HIV and drugs of abuse. | Q30332159 |
| | New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1 | Q33283034 |
| | Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine | Q33653493 |
| | Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization | Q33701016 |
| | An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction | Q33930664 |
| | Rats markedly escalate their intake and show a persistent susceptibility to reinstatement only when cocaine is injected rapidly | Q34118104 |
| | Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia | Q34196506 |
| | Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. | Q34330488 |
| | Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. | Q34343025 |
| | Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats | Q34351322 |
| | The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. | Q34385280 |
| | Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function | Q34461323 |
| | Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence | Q34629825 |
| | Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed | Q34715801 |
| | Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli | Q35085890 |
| | Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction | Q35528967 |
| | A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat | Q35828573 |
| | Recent understanding in the mechanisms of addiction | Q35882084 |
| | Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. | Q35957271 |
| | Changes in dopamine transporter binding in nucleus accumbens following chronic self-administration cocaine: heroin combinations | Q36392993 |
| | Cocaine use and HIV infection in intravenous drug users in San Francisco | Q36416785 |
| | Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding | Q36508575 |
| | Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS | Q36856162 |
| | HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes | Q36944251 |
| | The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats | Q36957664 |
| | Neuroimmunity, drugs of abuse, and neuroAIDS. | Q37015388 |
| | Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. | Q37104874 |
| | HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes | Q37196323 |
| | Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine | Q37244423 |
| | The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study | Q37275623 |
| | Effect of rate of delivery of intravenous cocaine on self-administration in rats | Q37291957 |
| | Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse | Q37314434 |
| | Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse | Q37316522 |
| | Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration | Q37349720 |
| | Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys | Q37352917 |
| | Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research. | Q37561360 |
| | Dopamine uptake: a review of progress in the last decade | Q37933525 |
| | Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia | Q40032000 |
| | Entangled epidemics: cocaine use and HIV disease | Q40789555 |
| | HIV-1 neuropathogenesis and abused drugs: current reviews, problems, and solutions | Q41096762 |
| | Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems | Q41555259 |
| | Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats | Q41573401 |
| | Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats | Q41602728 |
| | Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats | Q41991481 |
| | Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes | Q42039862 |
| | The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. | Q42517458 |
| | Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats | Q42519150 |
| | Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. | Q42539746 |
| | Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? | Q42541038 |
| | Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage | Q43154112 |
| | Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. | Q43578199 |
| | Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes | Q43896579 |
| | Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy | Q44692012 |
| | Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. | Q44809858 |
| | Decreased brain dopaminergic transporters in HIV-associated dementia patients | Q45023437 |
| | Glutamate release in the nucleus accumbens core is necessary for heroin seeking. | Q46691821 |
| | HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity. | Q46852604 |
| | Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis | Q46880735 |
| | Glutamate and aspartate levels in the nucleus accumbens during cocaine self-administration and extinction: a time course microdialysis study. | Q46947135 |
| | Striatal [125I]RTI-55 binding sites in cocaine-abusing humans | Q48013399 |
| | Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. | Q48126255 |
| | Synthesis of 2 beta-acyl-3 beta-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex | Q48137555 |
| | Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. | Q48177678 |
| | A kinetic study of the in vitro uptake of [3H]dopamine over a wide range of concentrations by rat striatal preparations | Q48276291 |
| | Striatal dopaminergic abnormalities in human cocaine users | Q48283085 |
| | Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. | Q48323776 |
| | In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density | Q48343641 |
| | Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. | Q48616658 |
| | HIV-associated brain pathology in the United Kingdom: an epidemiological study | Q48657818 |
| | Correlates of HIV infection among young adult short-term injection drug users. | Q50659913 |
| | Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine. | Q51550172 |
| | Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine. | Q51603004 |
| | High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. | Q51617568 |
| | Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. | Q51876339 |
| | The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. | Q54454547 |
| | The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis | Q72241128 |
| | A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants | Q73950418 |
| | Acute and chronic effects of cocaine on the immune system and the possible link to AIDS | Q74608049 |
| | A prospective study of HIV disease progression in female and male drug users | Q77323334 |
| P433 | issue | 3 | |
| P921 | main subject | striatum | Q1319792 |
| P304 | page(s) | 493-505 | |
| P577 | publication date | 2015-03-10 | |
| P1433 | published in | Journal of Neuroimmune Pharmacology | Q6295645 |
| P1476 | title | Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding | |
| P478 | volume | 10 | |